Bureau of Oceans and International Environmental and Scientific Affairs

GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner

Retrieved on: 
Monday, September 11, 2023
Cancer, MRFF, University, Royal Melbourne Hospital, Cancer Australia, Bureau of Oceans and International Environmental and Scientific Affairs, National Guideline Clearinghouse, GTG, The Royal Marsden NHS Foundation Trust, Risk, University of Melbourne, Policy, ASX, Breast, Research, Genomics, Prostate, History, Queen Mary University of London, General practice, Standard of care, Melanoma, Genetypes, Scores, Biostatistics, Health, Medical Research Future Fund, Primary care, Pharmaceutical industry, Vaccine

The grant will provide funding for the CASSOWARY Trial: a randomised controlled trial of the clinical utility and cost-effectiveness of a multi-cancer polygenic risk score in general practice.

Key Points: 
  • The grant will provide funding for the CASSOWARY Trial: a randomised controlled trial of the clinical utility and cost-effectiveness of a multi-cancer polygenic risk score in general practice.
  • GTG is the National Research Partner for trial which is to be led by Professor Jon Emery.
  • The trial results will inform future policy including the 5-year goal in the Australian Cancer Plan of using genomics for risk-stratified cancer screening.
  • As the sole industry partner, GTG will receive funding to cover the supply of test kits and the analysis of the sample returned.

DolCas Biotech Obtains its First Non-GMO Project Verified Label for MMP-50®

Retrieved on: 
Wednesday, September 13, 2023
ASC, DNA, Communication, Medicine, Human, Mineral, Matrix metalloproteinase, Aquaculture Stewardship Council, Bureau of Oceans and International Environmental and Scientific Affairs, Marketing, Horse, NSF, The Non-GMO Project, Matrix metalloproteinase inhibitor, GMO, Lipid, USP, Certification, Economic methodology, Vitamin, Beauty, Tilapia, USDA, Mukai Cold Process Fruit Barrelling Plant, Dog, Micronutrient, Health, Environment, News, NMI, Aquaculture, Dietary supplement

LANDING, N.J., Sept. 13, 2023 /PRNewswire/ -- DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New England green lipped mussel extract for human and pet health. MMP-50 is one of seven clinically researched ingredients in the innovative company's portfolio, and while MMP-50 is the first to receive the backing of the prestigious certification, CEO and founder, K. G. Rao affirms the company's plans to pursue the certification across its portfolio.

Key Points: 
  • LANDING, N.J., Sept. 13, 2023 /PRNewswire/ -- DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New England green lipped mussel extract for human and pet health.
  • The transparency efforts the Non-GMO Project spearheaded on the food front has translated to the supplement market.
  • DolCas voluntarily submitted MMP-50 for compliance evaluation with the Non-GMO Project standard.
  • Like the Non-GMO Verified Project, the ASC certificate is the most highly merited of third-party credentialing in its category.

Patient-led Innovations in Inflammatory Bowel Disease Take the Prize in Takeda Canada's Digital Health Challenge

Retrieved on: 
Tuesday, September 12, 2023
Cleveland Clinic, Mayo Clinic, Partnership, Crohn's disease, Bureau of Oceans and International Environmental and Scientific Affairs, Education, Inflammatory Bowel Diseases, Takeda, IBD, Health, Quality of life, Medicine, Research, Addenbrooke's Hospital, Harvard Medical School, Inflammatory bowel disease, Organization, Cambridge University Hospitals NHS Foundation Trust, Patient, Ulcerative colitis, Knowledge, Hospital, Ecosystem, CUH, Northwestern University, Addenbrooke, Pharmaceutical industry, Nursing

TORONTO, Sept. 12, 2023 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce two winners of the 2023 Takeda Canada Digital Health Innovation Challenge , a competition to identify and support innovative digital health solutions to improve patient outcomes and experiences.

Key Points: 
  • TORONTO, Sept. 12, 2023 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce two winners of the 2023 Takeda Canada Digital Health Innovation Challenge , a competition to identify and support innovative digital health solutions to improve patient outcomes and experiences.
  • This year's challenge winners are two patient-led organizations with disruptive digital solutions aimed at improving the patient journey in Inflammatory Bowel Disease (IBD), the most common forms being Ulcerative Colitis and Crohn's Disease.
  • Ayble Health is an all-in-one virtual gastroenterology platform that helps digestive disease patients, including those with inflammatory bowel disease, find long-term relief and control over their symptoms.
  • Partnering with Takeda Canada will help us empower more patients, transform their journey, and improve overall disease management."

National Sleep Foundation Reinforces Consistent Sleep Schedules with New Consensus Guideline

Retrieved on: 
Thursday, September 7, 2023
Consensus, Obesity, Bureau of Oceans and International Environmental and Scientific Affairs, Diabetes, Life, Cone Health Women's Hospital, NSF, Cardiovascular disease, Cancer, Inflammation, Doctor of Philosophy, Science, Harvard Medical School, Journal, MD, Guideline, National Sleep Foundation, Sleep medicine, DSM-IV codes, Nobel, Hospital, Health, Mental health, Nursing, Sleep, Research

WASHINGTON, Sept. 7, 2023 /PRNewswire/ -- The National Sleep Foundation (NSF) issued a new guideline emphasizing the benefit of consistent sleep schedules on health and performance. The results are from a consensus report published in Sleep Health®, the Journal of the National Sleep Foundation, under the original title The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel.

Key Points: 
  • Features evidence-based benefits for health and performance,
    WASHINGTON, Sept. 7, 2023 /PRNewswire/ -- The National Sleep Foundation (NSF) issued a new guideline emphasizing the benefit of consistent sleep schedules on health and performance.
  • The results are from a consensus report published in Sleep Health®, the Journal of the National Sleep Foundation, under the original title The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel .
  • NSF established an expert panel of some of the foremost authorities in sleep and circadian science to develop a consensus recommendation for consistent sleep schedules, reflecting an extensive analysis of the peer-reviewed literature on the subject.
  • "Maintaining consistent sleep and wake times and utilizing non-work days to help catch-up on sleep are two tools most members of the public can use to promote sleep health."

Imaging Endpoints Appoints Manish Sharma, MD as Chief Scientific Officer

Retrieved on: 
Wednesday, September 6, 2023
Metadata, Bureau of Oceans and International Environmental and Scientific Affairs, Cave rescue, Big data, Deep learning, Clinical trial, NDA, Cure, Doctor of Philosophy, Aptitude, Patient, Growth, ANDA, Research, IND, ChromeOS, Data science, Medical imaging, MD

SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment of Manish Sharma, MD as its Chief Scientific Officer.

Key Points: 
  • SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment of Manish Sharma, MD as its Chief Scientific Officer.
  • Dr Sharma, a radiologist with over 20 years of extensive experience in clinical research, medical imaging, and data science, joins Imaging Endpoints with a proven track record of excellence.
  • "Manish's extensive expertise and innovative approach align perfectly with our vision to 'Connect Imaging to the Cure,'" said Ronald Korn, MD, PhD, Chief Medical Officer and Founder of Imaging Endpoints.
  • Dr. Sharma will oversee Medical and Scientific Affairs as well as Research and Development at Imaging Endpoints.

Imaging Endpoints Appoints Manish Sharma, MD as Chief Scientific Officer

Retrieved on: 
Wednesday, September 6, 2023
Metadata, Bureau of Oceans and International Environmental and Scientific Affairs, Cave rescue, Big data, Deep learning, Clinical trial, NDA, Cure, Doctor of Philosophy, Aptitude, Patient, Growth, ANDA, Research, IND, ChromeOS, Data science, Medical imaging, MD

SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment of Manish Sharma, MD as its Chief Scientific Officer.

Key Points: 
  • SCOTTSDALE, Ariz., Sept. 6, 2023 /PRNewswire/ -- Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment of Manish Sharma, MD as its Chief Scientific Officer.
  • Dr Sharma, a radiologist with over 20 years of extensive experience in clinical research, medical imaging, and data science, joins Imaging Endpoints with a proven track record of excellence.
  • "Manish's extensive expertise and innovative approach align perfectly with our vision to 'Connect Imaging to the Cure,'" said Ronald Korn, MD, PhD, Chief Medical Officer and Founder of Imaging Endpoints.
  • Dr. Sharma will oversee Medical and Scientific Affairs as well as Research and Development at Imaging Endpoints.

CG Oncology Announces Key Executive Appointments in Commercialization, Medical and Manufacturing Operations

Retrieved on: 
Tuesday, September 5, 2023
Oncology, Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Immortalised cell line, Upjohn, GMP, Amgen, IIT, Medical Affairs Bureau, University, Bureau of Oceans and International Environmental and Scientific Affairs, Blas, University of Maryland, College Park, GU, Record, American Society of Pediatric Hematology/Oncology, Dartmouth–Hitchcock Medical Center, Bladder cancer, Multimedia, Research, Priscilla Chan, Assistant, AbCellera, National Cancer Institute, Urology, Patient, Division, Oslo-Fergene, Hematology, IND, Sanofi, Indian Institutes of Technology, Growth, Merck Serono, SVP, Chemical engineering, Caregiver, Disease, Management, Nursing, Photocure, Seagen, Pfizer

View the full release here: https://www.businesswire.com/news/home/20230905869419/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230905869419/en/
    Ambaw Bellete, President and Chief Operating Officer, CG Oncology (Photo: Business Wire)
    “CG Oncology is at an important stage in our growth, advancing our late-stage clinical pipeline to address unmet medical needs in bladder cancer.
  • Ambaw, Swapnil and Vijay bring decades of experience and proven track records in developing immunotherapy agents from research to commercialization,” said Arthur Kuan, Chief Executive Officer, CG Oncology.
  • Previously, Vijay was the VP, Clinical Development and Medical Affairs and a member of the executive leadership team at AVEO.
  • He was also SVP of Scientific Affairs at FerGene, leading Medical Affairs, Clinical Operations, Regulatory and Clinical Development.

Dario Publishes New Research Demonstrating Greater Engagemenet and Improved Clinical Outcomes Sustainable for Two Years

Retrieved on: 
Thursday, August 24, 2023
Conference, Bureau of Oceans and International Environmental and Scientific Affairs, Research, Diabetes, Doctor of Philosophy, Behavior, Dario

NEW YORK, Aug. 24, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the ADCES23 Annual Conference held earlier this month in Houston, Texas. The new research demonstrates Dario's ability to sustainably improve health outcomes for users with diabetes over a two-year period.

Key Points: 
  • The new research demonstrates Dario's ability to sustainably improve health outcomes for users with diabetes over a two-year period.
  • Dario's digital health solutions combine a clinically intelligent platform with billions of consumer insights to help drive sustainable behavior change to improve the management of chronic conditions and improve health outcomes.
  • The latest research analyzed the data of 119,482 Dario members to understand the relationship between improving engagement and health outcomes.
  • The results showed that during the two years of data analyzed in the research study, users improved engagement 29% over two years.

Achieving Success in Neuroscience Clinical Trials: An Integrated CRO Approach, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, August 22, 2023
Bureau of Oceans and International Environmental and Scientific Affairs, MSN, Clinical trial, Neuroscience, Biomarker, Cerebrospinal fluid, Doctor of Philosophy, United States Army Medical Department Center and School, MD, Laboratory, Blood, CSF, Diagnosis, Collaboration, Medical imaging

TORONTO, Aug. 22, 2023 /PRNewswire-PRWeb/ -- Neuroscience trials increasingly depend on non-clinical measures from early-stage development through pivotal trials. The introduction of diagnosis is done by gene, blood, cerebrospinal fluid (CSF) and imaging measures as well as accelerated approval with biomarker surrogate endpoints. Navigating this new landscape requires an integrated contract research organization (CRO) strategy for the development program and trials at each stage of the process.

Key Points: 
  • In this free webinar, learn how to deliver high-quality regulatory-compliant endpoints in neuroscience clinical trials.
  • The featured speakers will discuss how to integrate and manage imaging and liquid biomarkers in neuroscience therapeutic product development.
  • Attendees will learn how to apply lessons learned in conducting neuroscience clinical trials with an integrated CRO approach, including core labs and central labs.
  • TORONTO, Aug. 22, 2023 /PRNewswire-PRWeb/ -- Neuroscience trials increasingly depend on non-clinical measures from early-stage development through pivotal trials.

Colgate’s Bright Smiles Bright Futures® Program and Hip Hop Public Health Partner on Educational Song and Music Video featuring Doug E. Fresh to Improve Oral Health Awareness and Outcomes for Children

Retrieved on: 
Tuesday, August 15, 2023
Children, Music, Other Consumer, Health, Licensing (Entertainment), Entertainment, Celebrity, Family, Consumer, Dental, Parenting, Columbia University, Learning, Optimism, Travel, Bureau of Oceans and International Environmental and Scientific Affairs, Education, Culture, Teaching, Health equity, Health promotion, Multimedia, Creativity, Organization, Colgate, Student, Work, Oral hygiene, Health literacy, Dentistry, Nursing

The song, performed by entertainment icon and Hip Hop Public Health co-founder Doug E. Fresh, advances BSBF’s mission to close the oral healthcare gap.

Key Points: 
  • The song, performed by entertainment icon and Hip Hop Public Health co-founder Doug E. Fresh, advances BSBF’s mission to close the oral healthcare gap.
  • Part of the song is also performed in Spanish by Dr. Monique “Docta Mo Flow” Hedmann-Maxey, styled with hip-hop and reggaeton world beat.
  • Hip Hop Public Health is an internationally recognized organization that creates research-based educational resources by harnessing the power of music and culture to improve health in communities that are underserved.
  • All of Hip Hop Public Health’s 200+ educational resources are available to stream for free, removing access barriers for teaching, learning and health literacy.